NCT02968810View on ClinicalTrials.gov

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

May 3, 2023

Study Completion Date

December 23, 2025

Conditions
CirrhosisHepatocellular Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Placebo Administration

Given PO

OTHER

Questionnaire Administration

Ancillary studies

DRUG

Simvastatin

Given PO

Trial Locations (5)

20007

MedStar Georgetown University Hospital, Washington D.C.

60611

Northwestern University, Chicago

90048

Cedars Sinai Medical Center, Los Angeles

00927

Centro Comprensivo de Cancer de UPR, San Juan

00936

University of Puerto Rico, San Juan

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH